---
id: system-diabetes-pancreatitis-comorbidity-memo
type: system
topic: diabetes
last_compiled_at: 2026-04-24
owner: codex
status: active
language: en
verification_status: compiled
decision_grade: no
language_qa_status: light_checked
---

# Diabetes Pancreatitis Comorbidity Memo

- Date: `2026-04-24`
- Scope: `src-diabetes-010`, with DKA/pancreatic-disease context from `src-diabetes-023`

This memo exists to prevent pancreatitis from being reduced to a generic comorbidity bullet.

## Core Takeaway

`diabetes and pancreatitis should be modeled as a bidirectional comorbidity problem that can complicate diabetes management and DKA care, not as a one-way causal explanation`

## Main Anchor

Main source:

- [src-diabetes-010 deep extraction round 1](src-diabetes-010-deep-extraction-round1.md)

Current compiled evidence supports:

- diabetes in cats frequently coexists with pancreatitis
- the exact pathogenetic association is not definitively established
- the association is framed as most likely bidirectional
- concurrent pancreatitis commonly leads to difficulties in diabetes management

## Context Anchor

`src-diabetes-023` adds cross-species pancreatic disease and ketoacidosis context.

Use it for:

- background pancreatic disease context
- DKA context
- hormone/drug interaction branch awareness

Do not use it for:

- feline-only pancreatitis prevalence
- feline-only DKA management recommendations
- herbal remedy promotion

## Current Branch Meaning

Pancreatitis should appear in:

- risk and recognition, because it may coexist with diabetes and complicate presentation
- translation, because diabetes management can become harder when pancreatitis coexists
- synthesis, because it blocks a clean one-pathway diabetes story
- DKA discussion, because pancreatitis may increase management complexity

## What The Module Can Say Now

- pancreatitis is a high-priority comorbidity branch
- causality should remain cautious
- bidirectional association is the safest current frame
- concurrent pancreatitis can make diabetes and DKA management harder

## What The Module Should Not Say Yet

- do not claim diabetes causes pancreatitis or pancreatitis causes diabetes as a settled one-way pathway
- do not provide a pancreatitis diagnostic algorithm from the current compiled layer alone
- do not quantify outcome impact without full-text review
- do not merge pancreatitis with endocrine-secondary diabetes; it is a different branch

## Best Write-Back Targets

- [risk and recognition](../../topics/diabetes/risk-and-recognition.md)
- [translation brief](../../topics/diabetes/translation-brief.md)
- [synthesis index](../../topics/diabetes/synthesis-index.md)
- [current state dashboard](../../topics/diabetes/current-state-dashboard.md)

## Promotion Judgment

- repeated? `yes`
- structurally clarifying? `yes`
- evidence-safe enough for this layer? `yes, for bidirectional-comorbidity boundary; no, for causality or protocol`
- smallest durable home: `memo + recognition write-back + translation write-back`

### Decision

- promote
